← Leaderboards
Karen M Prestwood
University Of Connecticut Sch Of Med/Dnt
$365,671
Attributed
$365,671
Total exposure
17
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $63.3K · FY2005–06$100K$75K$50K$25K$0
'05
'06
Funding mix
By agency
NIH$2,200,372 · 18
By mechanism
P20$1,834,701 · 2
M01$365,671 · 15
P60$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Anne M Delany$6,173,630
- Donald Kent Morest$3,944,878
- Blanka Rogina$6,290,467
- Sunil Wadhwa$4,854,323
- Justin D. Radolf$26,431,208
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectFemaleBone MetabolismEstrogensPostmenopauseHuman Therapy EvaluationBone DensityHormone TherapyHuman Old Age (65+)Women'S HealthOsteoporosisBiomarkerDosageVitamin DNutrition Related TagClinical TrialsEstrogen InhibitorDietary CalciumCalciumDrug Screening /EvaluationBone FractureAgingDietary Supplements
Grant awards (75)
SOY AND ISOFLAVONES$7,805
M01 · FY2006 · RR · contact PI
SOY AND ISOFLAVONES$61,711
M01 · FY2005 · RR
HERBAL THERAPY FOR HOT FLASHES$935
M01 · FY2005 · RR
THERAPEUTIC TOUCH$624
M01 · FY2005 · RR
Exploratory Program Grant for Frontier Medicine$623,864
P20 · FY2004 · AT
Soy and Isoflavones$82,909
M01 · FY2004 · RR
HealthMat$3,439
M01 · FY2004 · RR
Vitamin D in a Nursing Home$3,056
M01 · FY2004 · RR
Exploratory Program Grant for Frontier Medicine$607,805
P20 · FY2003 · AT
Exploratory Program Grant for Frontier Medicine$603,032
P20 · FY2002 · AT
EFFECT OF LOW DOSE ESTROGEN AND CALCIUM BONE TURNOVER IN OLDER WOMEN$0
M01 · FY2002 · RR
HORMONE REPLACEMENT THERAPY ON BONE TURNOVER AND DENSITY IN OLDER WOMEN$0
P60 · FY2002 · AG
Effect of Theapeutic Touch on Bone Formation in Postmenopausal Women After Wrist$0
P20 · FY2002 · AT
EFFECT OF MICRONIZED PROGESTERONE ON MARKERS OF BONE TURNOVER$0
M01 · FY2002 · RR
EFFECT OF HORMONE REPLACEMENT THERAPY ON BONE IN OLDER WOMEN$0
M01 · FY2002 · RR
PATHOGENESIS OF OSTEOPOROSIS IN OLDER WOMEN$0
M01 · FY2002 · RR
EFFECT OF SHORT TERM ESTROGEN WITHDRAWAL ON GENE EXPRESSION OF LOCAL FACTORS$0
M01 · FY2002 · RR
EFFECT OF IDOXIFENE ON BONE HISTOMORPHOMETRY IN POSTMENOPAUSAL WOMEN$0
M01 · FY2002 · RR
BONE TURNOVER AND RESPONSE TO ESTROGEN IN OLDER AFRICAN-AMERICAN, CAUCASIAN$0
M01 · FY2002 · RR
RALOXIFENE HCL VS ESTROGEN--EFFECTS IN BONE IN POSTMENOPAUSAL WOMEN$0
M01 · FY2002 · RR
EFFECT OF LOW DOSE ESTROGEN AND CALCIUM BONE TURNOVER IN OLDER WOMEN$4,361
M01 · FY2001 · RR
EFFECT OF MICRONIZED PROGESTERONE ON MARKERS OF BONE TURNOVER$4,361
M01 · FY2001 · RR
EFFECT OF HORMONE REPLACEMENT THERAPY ON BONE IN OLDER WOMEN$4,361
M01 · FY2001 · RR
PATHOGENESIS OF OSTEOPOROSIS IN OLDER WOMEN$4,361
M01 · FY2001 · RR
EFFECT OF SHORT TERM ESTROGEN WITHDRAWAL ON GENE EXPRESSION OF LOCAL FACTORS$4,361
M01 · FY2001 · RR
EFFECT OF IDOXIFENE ON BONE HISTOMORPHOMETRY IN POSTMENOPAUSAL WOMEN$4,361
M01 · FY2001 · RR
BONE TURNOVER AND RESPONSE TO ESTROGEN IN OLDER AFRICAN-AMERICAN, CAUCASIAN$4,361
M01 · FY2001 · RR
RALOXIFENE HCL VS ESTROGEN--EFFECTS IN BONE IN POSTMENOPAUSAL WOMEN$4,361
M01 · FY2001 · RR
PATHOGENESIS OF OSTEOPOROSIS IN OLDER WOMEN$0
M01 · FY2001 · RR
RALOXIFENE HCL VS ESTROGEN--EFFECTS IN BONE IN POSTMENOPAUSAL WOMEN$0
M01 · FY2001 · RR
RALOXIFENE HCL VS ESTROGEN--EFFECTS IN BONE IN POSTMENOPAUSAL WOMEN$0
M01 · FY2001 · RR
EFFECT OF LOW DOSE ESTROGEN AND CALCIUM BONE TURNOVER IN OLDER WOMEN$0
M01 · FY2001 · RR
EFFECT OF LOW DOSE ESTROGEN AND CALCIUM BONE TURNOVER IN OLDER WOMEN$0
M01 · FY2001 · RR
BONE TURNOVER AND RESPONSE TO ESTROGEN IN OLDER AFRICAN-AMERICAN, CAUCASIAN$0
M01 · FY2001 · RR
BONE TURNOVER AND RESPONSE TO ESTROGEN IN OLDER AFRICAN-AMERICAN, CAUCASIAN$0
M01 · FY2001 · RR
EFFECT OF IDOXIFENE ON BONE HISTOMORPHOMETRY IN POSTMENOPAUSAL WOMEN$0
M01 · FY2001 · RR
EFFECT OF IDOXIFENE ON BONE HISTOMORPHOMETRY IN POSTMENOPAUSAL WOMEN$0
M01 · FY2001 · RR
EFFECT OF SHORT TERM ESTROGEN WITHDRAWAL ON GENE EXPRESSION OF LOCAL FACTORS$0
M01 · FY2001 · RR
EFFECT OF SHORT TERM ESTROGEN WITHDRAWAL ON GENE EXPRESSION OF LOCAL FACTORS$0
M01 · FY2001 · RR
PATHOGENESIS OF OSTEOPOROSIS IN OLDER WOMEN$0
M01 · FY2001 · RR
EFFECT OF HORMONE REPLACEMENT THERAPY ON BONE IN OLDER WOMEN$0
M01 · FY2001 · RR
EFFECT OF HORMONE REPLACEMENT THERAPY ON BONE IN OLDER WOMEN$0
M01 · FY2001 · RR
EFFECT OF MICRONIZED PROGESTERONE ON MARKERS OF BONE TURNOVER$0
M01 · FY2001 · RR
EFFECT OF MICRONIZED PROGESTERONE ON MARKERS OF BONE TURNOVER$0
M01 · FY2001 · RR
HORMONE REPLACEMENT THERAPY ON BONE TURNOVER AND DENSITY IN OLDER WOMEN$0
P60 · FY2001 · AG
BONE TURNOVER AND RESPONSE TO ESTROGEN IN OLDER AFRICAN-AMERICAN, CAUCASIAN$19,111
M01 · FY2000 · RR
EFFECT OF SHORT TERM ESTROGEN WITHDRAWAL ON GENE EXPRESSION OF LOCAL FACTORS$19,111
M01 · FY2000 · RR
EFFECT OF IDOXIFENE ON BONE HISTOMORPHOMETRY IN POSTMENOPAUSAL WOMEN$19,111
M01 · FY2000 · RR
RALOXIFENE HCL VS ESTROGEN--EFFECTS IN BONE IN POSTMENOPAUSAL WOMEN$19,111
M01 · FY2000 · RR
PATHOGENESIS OF OSTEOPOROSIS IN OLDER WOMEN$19,111
M01 · FY2000 · RR
EFFECT OF LOW DOSE ESTROGEN AND CALCIUM BONE TURNOVER IN OLDER WOMEN$19,111
M01 · FY2000 · RR
EFFECT OF HORMONE REPLACEMENT THERAPY ON BONE IN OLDER WOMEN$19,111
M01 · FY2000 · RR
EFFECT OF MICRONIZED PROGESTERONE ON MARKERS OF BONE TURNOVER$19,083
M01 · FY2000 · RR
EFFECT OF SHORT TERM ESTROGEN WITHDRAWAL ON GENE EXPRESSION OF LOCAL FACTORS$4,361
M01 · FY2000 · RR
EFFECT OF SHORT TERM ESTROGEN WITHDRAWAL ON GENE EXPRESSION OF LOCAL FACTORS$4,361
M01 · FY2000 · RR
EFFECT OF LOW DOSE ESTROGEN AND CALCIUM BONE TURNOVER IN OLDER WOMEN$4,361
M01 · FY2000 · RR
EFFECT OF LOW DOSE ESTROGEN AND CALCIUM BONE TURNOVER IN OLDER WOMEN$4,361
M01 · FY2000 · RR
Effect of enbrel on bone turnover in postmenopausal women$0
M01 · FY2000 · RR
Effect of enbrel on bone turnover in postmenopausal women$0
M01 · FY2000 · RR
EFFECT OF IDOXIFENE ON BONE HISTOMORPHOMETRY IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
EFFECT OF IDOXIFENE ON BONE HISTOMORPHOMETRY IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
BONE TURNOVER AND RESPONSE TO ESTROGEN IN OLDER AFRICAN-AMERICAN, CAUCASIAN$0
M01 · FY2000 · RR
BONE TURNOVER AND RESPONSE TO ESTROGEN IN OLDER AFRICAN-AMERICAN, CAUCASIAN$0
M01 · FY2000 · RR
Effect of enbrel on bone turnover in postmenopausal women$0
M01 · FY2000 · RR
RALOXIFENE HCL VS ESTROGEN--EFFECTS IN BONE IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
EFFECT OF MICRONIZED PROGESTERONE ON MARKERS OF BONE TURNOVER$0
M01 · FY2000 · RR
EFFECT OF MICRONIZED PROGESTERONE ON MARKERS OF BONE TURNOVER$0
M01 · FY2000 · RR
RALOXIFENE HCL VS ESTROGEN--EFFECTS IN BONE IN POSTMENOPAUSAL WOMEN$0
M01 · FY2000 · RR
EFFECT OF HORMONE REPLACEMENT THERAPY ON BONE IN OLDER WOMEN$0
M01 · FY2000 · RR
EFFECT OF HORMONE REPLACEMENT THERAPY ON BONE IN OLDER WOMEN$0
M01 · FY2000 · RR
PATHOGENESIS OF OSTEOPOROSIS IN OLDER WOMEN$0
M01 · FY2000 · RR
HORMONE REPLACEMENT THERAPY ON BONE TURNOVER AND DENSITY IN OLDER WOMEN$0
P60 · FY2000 · AG
HORMONE REPLACEMENT THERAPY ON BONE TURNOVER AND DENSITY IN OLDER WOMEN$0
P60 · FY2000 · AG
PATHOGENESIS OF OSTEOPOROSIS IN OLDER WOMEN$0
M01 · FY2000 · RR
HORMONE REPLACEMENT THERAPY ON BONE TURNOVER AND DENSITY IN OLDER WOMEN$0
P60 · FY2000 · AG